WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Syndax Pharmaceuticals Inc. (SNDX) on Tuesday reported a loss of $39.2 million in its fourth quarter.
The Waltham, Massachusetts-based company said it had a loss of 62 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
For the year, the company reported a loss of $149.3 million, or $2.46 per share.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SNDX at https://www.zacks.com/ap/SNDX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.